Buranrat Benjaporn, Mairuae Nootchanat, Kanchanarach Watchara
Faculty of Medicine, Mahasarakham University, Muang, Maha Sarakham 44000, Thailand.
Microbiology and Applied Microbiology Research Unit, Department of Biology, Faculty of Science, Mahasarakham University, Maha Sarakham 44150, Thailand.
Biomed Rep. 2017 Apr;6(4):441-448. doi: 10.3892/br.2017.871. Epub 2017 Mar 10.
The aim of the present study was to investigate the molecular mechanisms underlying (CF) Dyer-induced cancer cell death and antimigratory effects in HepG2 liver cancer cells. The cytotoxic, antiproliferative and antimigratory effects of CF leaf extract on human liver cancer HepG2 cell lines were evaluated using sulforhodamine B, colony formation, and wound healing assays. In addition, apoptosis induction mechanisms were investigated via reactive oxygen species (ROS) formation, caspase 3 activities, and mitochondrial membrane potential (ΔΨm) disruption. Gene expression and apoptosis-associated protein levels were measured by reverse transcription-quantitative polymerase chain reaction and western blotting. CF induced HepG2 cell death in a time- and dose-dependent manner with half maximal inhibitory concentration values of 219.03±9.96 and 124.90±6.86 µg/ml at 24 and 48 h, respectively. Treatment with CF caused a significant and dose-dependent decrease in colony forming ability and cell migration. Furthermore, the present study demonstrated that CF induced ROS formation, increased caspase 3 activities, decreased the ΔΨm, and caused HepG2 apoptosis. CF marginally decreased the expression level of the cell cycle regulatory protein, ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) and the downstream protein, cyclin dependent kinase 6. Additionally, CF significantly enhanced p21 levels, reduced cyclin D1 protein levels and triggered cancer cell death. CF leaf extracts induced cell death, stimulated apoptosis and inhibited migration in HepG2 cells. Thus, CF may be useful for developing an anticancer drug candidate for the treatment of liver cancer.
本研究的目的是探讨(CF)戴尔诱导肝癌细胞系HepG2细胞死亡和抗迁移作用的分子机制。使用磺酰罗丹明B、集落形成和伤口愈合试验评估了CF叶提取物对人肝癌HepG2细胞系的细胞毒性、抗增殖和抗迁移作用。此外,通过活性氧(ROS)生成、半胱天冬酶3活性和线粒体膜电位(ΔΨm)破坏研究了凋亡诱导机制。通过逆转录定量聚合酶链反应和蛋白质印迹法测量基因表达和凋亡相关蛋白水平。CF以时间和剂量依赖性方式诱导HepG2细胞死亡,在24小时和48小时时半数最大抑制浓度值分别为219.03±9.96和124.90±6.86μg/ml。CF处理导致集落形成能力和细胞迁移显著且剂量依赖性降低。此外,本研究表明CF诱导ROS生成、增加半胱天冬酶3活性、降低ΔΨm并导致HepG2细胞凋亡。CF略微降低了细胞周期调节蛋白、ras相关C3肉毒杆菌毒素底物1(rho家族,小GTP结合蛋白Rac1)和下游蛋白细胞周期蛋白依赖性激酶6的表达水平。此外,CF显著提高p21水平、降低细胞周期蛋白D1蛋白水平并引发癌细胞死亡。CF叶提取物诱导HepG2细胞死亡、刺激凋亡并抑制迁移。因此,CF可能有助于开发用于治疗肝癌的抗癌候选药物。